RhumbLine Advisers
APRE icon

RhumbLine Advisers’s Aprea Therapeutics APRE Stock Holding History

RhumbLine Advisers’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-398
Closed -$309K – 2977
2020
Q2 		$309K Buy
398
+80
+25% +$62.1K ﹤0.01% 2562
2020
Q1 		$221K Buy
+318
New +$221K ﹤0.01% 2539